Subjective cognitive decline domain improves accuracy of plasma Aβ 42 /Aβ 40 for preclinical Alzheimer's disease diagnosis: The SILCODE study

Affiliations

• ¹ Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
• ² Department of Neurology, Sir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
• ³ Department of Neurology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, China.
• ⁴ Heilongjiang Key Laboratory of Ischemic Stroke Prevention and Treatment, Mudanjiang, Heilongjiang 157011, China.
• ⁵ Department of Neurology, Tangshan Central Hospital, Tangshan, Hebei 063000, China.
• ⁶ Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of the Ministry of Education, Beijing 100053, China.
• ⁷ Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, China.
• ⁸ Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
• ⁹ Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing 100053, China.
• ¹⁰ Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing 100053, China.
• ¹¹ School of Biomedical Engineering, Hainan University, Haikou, Hainan 570228, China.
• ¹² Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing 100053, China.
• ¹³ National Clinical Research Center for Geriatric Disorders, Beijing 100053, China.
• ¹⁴ Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong 518132, China.